Rhythm Biotherapeutics
PrivateLast Round
Seed
Dec 5, 2025
Total Funding Raised
$4.31M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rhythm Biotherapeutics Inc. is a biotechnology company developing exosome-based therapies to prevent and cure atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhythm Biotherapeutics Comparables
Compare Rhythm Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inomagen Therapeutics | 78% | |
| Acesion Pharma | 64% | |
| RION | 59% |
Rhythm Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2025 | ||||
| Grant | Nov 15, 2024 | ||||
| Seed | Nov 15, 2024 |
Rhythm Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital BioVentures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2025
Raised $4M in seed funding.
- Nov 15, 2024
$235K round led by Ken Newport
Rhythm Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rhythm Biotherapeutics's valuation, stock price, and market status.
Is Rhythm Biotherapeutics a public or private company?
Rhythm Biotherapeutics is a private company.
What is the current stock price of Rhythm Biotherapeutics?
Rhythm Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Rhythm Biotherapeutics worth (valuation)?
Valuation information for Rhythm Biotherapeutics is not publicly available.
Can I buy Rhythm Biotherapeutics stock?
Rhythm Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rhythm Biotherapeutics's last funding round?
Rhythm Biotherapeutics's most recent funding round was Seed on December 5, 2025.
Who are the main investors in Rhythm Biotherapeutics?
Key investors in Rhythm Biotherapeutics include Capital BioVentures.
Will Rhythm Biotherapeutics IPO soon?
No public IPO plans have been announced for Rhythm Biotherapeutics.
How can I track Rhythm Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rhythm Biotherapeutics's secondary market activity and sign up for updates.